DEFINITIVE CONTRACT
Active75F40126C00093
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$456.7K
obligated · signed 2 months ago
TO PROVIDE RESEARCH AND DEVELOPMENT SERVICES TO DESIGN, DEVELOP, VALIDATE, AND DELIVER AN AI-ASSISTED DIGITAL TWIN PLATFORM FOR PHARMACEUTICAL LYOPHILIZATION PROCESS DEVELOPMENT AND SCALE-UP.
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2028
with all options
Loading status
Estimated start: Sep 29, 2027
UNIVERSITY OF MASSACHUSETTS LOWELL
Contract 75F40126C00093
UEI
LTNVSTJ3R6D5
Parent Company
UNIVERSITY OF MASSACHUSETTS LOWELL
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$456,721
Base + Exercised Options
$456,721
Total Ceiling Value
$456,721
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.